Last week, we were excited to announce the nomination of our first smart GIP/GLP-1 pancreatic gene therapy lead candidate, RJVA-002, which is designed for the treatment of obesity ... efficacy of RJVA ...
Last week, we were excited to announce the nomination of our first smart GIP/GLP-1 pancreatic gene therapy lead candidate, RJVA-002, which is designed for the treatment of obesity ... efficacy of RJVA ...
Cash, cash equivalents and marketable securities of $372.8 million, including $172.7 million equity raise in September, expected to provide runway into 2028 ...
News Medical on MSN15h
Community-led intervention curbs childhood obesity and boosts quality of lifeThe RESPOND trial adapted to COVID-19 disruptions by shifting to a cluster-parallel randomized design, enabling analysis ...
Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback